845306-08-3

Basic information

• Product Name: TERT-BUTYL 5-BROMOPYRIDINE-2-CARBOXYLATE 98
• Synonyms: TERT-BUTYL 5-BROMOPYRIDINE-2-CARBOXYLATE 98;5-Bromo-pyridine-2-carboxylic acid tert-butyl ester;tert-Butyl 5-bromopyridine-2-carboxylate 98%;5-Bromopyridine-2-carboxylic acid t-butyl ester;tert-butyl 5-bromopicolinate;2-Pyridinecarboxylic acid, 5-broMo-, 1,1-diMethylethyl ester;5-Bromo-2-pyridinecarboxylic acid 1,1-dimethylethyl ester;5-Bromopicolinic acid tert-butyl ester
• CAS NO: 845306-08-3
• Molecular Formula: C₁₀H₁₂BrNO₂
• Molecular Weight: 258.1138
• Product Categories: blocks;Bromides;Carboxes;Pyridines
• Mol File: 845306-08-3.mol

Chemical Properties

• Melting Point: 92-94
• Boiling Point: 318℃
• Flash Point: 146℃
• Appearance: /
• Density: 1.385
• Vapor Pressure: 0.00038mmHg at 25°C
• Refractive Index: 1.531
• Storage Temp.: Keep Cold
• PKA: -0.52±0.10(Predicted)
• CAS DataBase Reference: TERT-BUTYL 5-BROMOPYRIDINE-2-CARBOXYLATE 98(CAS DataBase Reference)
• NIST Chemistry Reference: TERT-BUTYL 5-BROMOPYRIDINE-2-CARBOXYLATE 98(845306-08-3)
• EPA Substance Registry System: TERT-BUTYL 5-BROMOPYRIDINE-2-CARBOXYLATE 98(845306-08-3)

Safety Data

• Hazard Codes: Xi
• Hazardous Substances Data: 845306-08-3(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Industry:
TERT-BUTYL 5-BROMOPYRIDINE-2-CARBOXYLATE 98 is used as a key intermediate in the synthesis of various drugs and pharmaceuticals for its ability to facilitate the creation of new chemical compounds with potential therapeutic applications.
Used in Research and Development:
Due to its high purity, TERT-BUTYL 5-BROMOPYRIDINE-2-CARBOXYLATE 98 is utilized as a reliable component in research and development processes, ensuring the quality and efficacy of experimental pharmaceuticals and contributing to the advancement of medicinal chemistry.

InChI:InChI=1/C10H12BrNO2/c1-10(2,3)14-9(13)8-5-4-7(11)6-12-8/h4-6H,1-3H3

Upstream product

• 29682-15-3 methyl 5-bromopicolinate 
• 75-65-0 tert-butyl alcohol 
• 30766-11-1 5-bromoisonicotinic acid 
• 36805-97-7 N,N-dimethylformamide di-tert-butyl acetal 

Downstream Products

• 30766-11-1 5-bromoisonicotinic acid 
• 1300728-36-2 tert-butyl 5H-pyrido[3,2-b]indole-2-carboxylate 
• 93835-05-3 3-tert-butoxycarbonyl-β-carboline 
• 943844-15-3 tert-butyl 5-formylpicolinate 
• 1403333-23-2 (S)-N-(1-(3-(3-Chloro-4-cyano-5-fluorophenyl)-1H-pyrazol-1-yl)propan-2-yl)-3,3'-bipyridine-6-carboxamide 
• 1214339-84-0 3,3'-bipyridine-6-carboxylic acid 
• 1354353-90-4 5-(3-fluorophenyl)-N-((2'-(trifluoromethyl)-2,4'-bipyridin-S-yl)methyl)picolinamide 

Relevant articles and documents

BENZAMIDE CGRP RECEPTOR ANTAGONISTS

The present invention is directed to benzamide compounds which are antagonists of CGRP receptors and useful in the treatment or prevention of diseases in which CGRP is involved, such as migraine. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which CGRP is involved.

ANDROGEN RECEPTOR MODULATING CARBOXAMIDES

Compounds of formula (I) or (II) wherein Rx, Rz, R9, R10, R14, R14′, R15, R15′, A and B are as defined in the claims and pharmaceutically acceptable salts and esters thereof, are disclosed. The compounds possess utility as tissue-selective androgen receptor modulators (SARM) and are useful as medicaments in the treatment of prostate cancer and other AR dependent conditions and diseases where AR antagonism is desired.

ANDROGEN RECEPTOR MODULATING CARBOXAMIDES

Compounds of formula (I) wherein Rx, Rz, R9, R10, R14, R14', R15, R15', A and B are as defined in the claims and pharmaceutically acceptable salts and esters thereof, are disclosed. The compounds possess utility as tissue-selective androgen receptor modulators (SARM) and are particularly useful as medicaments in the treatment of prostate cancer and other AR dependent conditions and diseases where AR antagonism is desired.

Direct C-2 arylation of alkyl 4-thiazolecarboxylates: New insights in synthesis of heterocyclic core of thiopeptide antibiotics

(Chemical Equation Presented) The Pd(0)-catalyzed regioselective C-2 (hetero)arylation of tert-butyl 4-thiazolecarboxylate with a broad (hetero)aryl halide is reported, including the direct coupling of pyridinyl halides. The process has allowed the preparation of valuable 2-pyridynyl-4- thiazolecarboxylates which are components of the complex heterocyclic core of thiopeptides antibiotics. As a first application, a synthesis of a tert-butyl sulfomycinamate thio-analogue from tert-butyl 4-thiazolecarboxylate is here described through a three-step direct pyridinylation, halogenation, and Stille cross-coupling sequence.

METHYLENE DIPIPERIDINE DERIVATIVES

The present invention relates to novel methylene dipiperidine derivatives having pharmacological activity, processes for their preparation, to compositions containing them and to their use in the treatment of neurological and psychiatric disorders.

Tetrahydronaphthyridine derivates useful as histamine H3 receptor ligands

The invention relates to tetrahydronaphthyridine derivatives having formula (I) and to processes for the preparation of, intermediates used in the preparation of, compositions containing and the uses of, such derivatives. Said tetrahydronaphthyridine derivatives are H3 ligands and are useful in numerous diseases, disorders and conditions, in particular inflammatory, allergic and respiratory diseases, disorders and conditions.

SUBSTITUTED PIPERIDINES AS HISTAMINE H3 RECEPTOR LIGANDS

The present invention relates to novel piperidine ether derivatives having affinity for the histamine H3 receptor, processes for their preparation, to compositions containing them and to their use in the treatment of neurological and psychiatric disorders.